SINGLE-USE BIOREACTOR MARKET ANALYSIS

Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024
Code : CMI5358
Pages :170
Formats :
Excel and PDF
Industry : Biotechnology

Market Concentration and Competitive Landscape

Single-Use Bioreactor Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising Demand for Increased Bioproduction Capacity

Global demand for biologics has grown substantially in recent years, driven by the expanding markets for vaccines, monoclonal antibodies, and other biomolecules. As biopharmaceutical pipelines continue delivering promising new drug candidates, the need to scale up biomanufacturing capabilities is increasingly crucial. However, building additional stainless-steel facilities requires sizable capital investments and can take 2-3 years to complete. In contrast, single-use bioreactors provide a faster and more cost-effective means to accelerate bioproduction without significant facility expansion. Their implementation can help gain vital biomanufacturing capacity within a much shorter timeframe to better address market needs. By offering a highly scalable approach, single-use bioreactors have enabled facilities to smoothly transition production volumes across different batch and product sizes. Their modular, standardized design allows for more predictable scale-up studies compared to conventional systems.

Key Players Insights